These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


206 related items for PubMed ID: 6166685

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Antigen recognition in induction of immunity.
    Diener E, Langman RE.
    Prog Allergy; 1975; 18():6-42. PubMed ID: 50600
    [No Abstract] [Full Text] [Related]

  • 23. Radioiodine-labeled antibody test for the detection of membrane antigens associated with Epstein-Barr virus.
    Hewetson JF, Gothoskar B, Klein G.
    J Natl Cancer Inst; 1972 Jan; 48(1):87-94. PubMed ID: 4347031
    [No Abstract] [Full Text] [Related]

  • 24. Specificity of monoclonal antibodies to an EBV transformed B-cell line.
    Schröder J, Suomalainen HA, Parkkinen E, Lundqvist C, Wada G, Koskimies S.
    Med Biol; 1982 Oct; 60(5):255-9. PubMed ID: 6296556
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Increase in Gross (G) antigen sites on the surface of AKR virus-induced rat lymphoma cells after treatment with trypsin.
    Brandchaft PB, Boone CW.
    J Immunol; 1974 Jul; 113(1):94-102. PubMed ID: 4364955
    [No Abstract] [Full Text] [Related]

  • 28. Relationship of Epstein-Barr virus-induced membrane antigens in lymphoid cells to viral envelope antigens.
    Gerber P, Goldstein G.
    J Immunol; 1970 Sep; 105(3):793-5. PubMed ID: 4318485
    [No Abstract] [Full Text] [Related]

  • 29. T cell repertoire and Epstein-Barr virus-specific T cell response in chronic active Epstein-Barr virus infection: a case study.
    Gallot G, Hamidou MA, Clémenceau B, Gaschet J, Tiberghien P, Ferrand C, Vivien R, Barbarot S, Coste-Burel M, Moreau A, Vié H.
    Clin Immunol; 2006 Apr; 119(1):79-86. PubMed ID: 16386957
    [Abstract] [Full Text] [Related]

  • 30. The human T cell immune response to Epstein-Barr virus.
    Landais E, Saulquin X, Houssaint E.
    Int J Dev Biol; 2005 Apr; 49(2-3):285-92. PubMed ID: 15906243
    [Abstract] [Full Text] [Related]

  • 31. Characterization of a xenoantiserum produced against three molar KCl-solubilized antigens obtained from a non-T, non-B (pre-B) acute lymphoblastic leukemia cell line.
    LeBien TW, Hurwitz RL, Kersey JH.
    J Immunol; 1979 Jan; 122(1):82-8. PubMed ID: 310838
    [No Abstract] [Full Text] [Related]

  • 32. Viral aetiopathogenesis of tumors.
    Klein E.
    Boll Ist Sieroter Milan; 1971 Jan; 50(3):140-51. PubMed ID: 4111986
    [No Abstract] [Full Text] [Related]

  • 33. Antigen-binding structures on the surface of T lymphocytes.
    Hämmerling GJ, McDevitt HO.
    Isr J Med Sci; 1975 Dec; 11(12):1331-41. PubMed ID: 56324
    [No Abstract] [Full Text] [Related]

  • 34. Immunity in leukemia.
    Gatti RA.
    Boll Ist Sieroter Milan; 1974 Dec; 53(1):suppl:275-81. PubMed ID: 4277522
    [No Abstract] [Full Text] [Related]

  • 35. Antigenic determinants common to established human B-cell lines, but not shared by human T-cell lines (molt and sommer).
    Takada Y, Takada A, Minowada J.
    Clin Exp Immunol; 1975 Aug; 21(2):267-77. PubMed ID: 52426
    [Abstract] [Full Text] [Related]

  • 36. Changes in receptor isotype and T/B ratio in an antigen-binding cell population after in vitro immunization.
    Merrill JE, Ashman RF.
    J Immunol; 1979 Jul; 123(1):434-41. PubMed ID: 376744
    [No Abstract] [Full Text] [Related]

  • 37. Surface markers on human B and T lymphocytes. VIII. Association between complement and Epstein-Barr virus receptors on human lymphoid cells.
    Jondal M, Klein G, Oldstone MB, Bokish V, Yefenof E.
    Scand J Immunol; 1976 Jul; 5(4):401-10. PubMed ID: 59946
    [Abstract] [Full Text] [Related]

  • 38. Critical evaluation of B and T cell markers in man.
    Preud'Homme JL, Seligmann M.
    Rheumatology; 1975 Jul; 6():178-89. PubMed ID: 53874
    [No Abstract] [Full Text] [Related]

  • 39. A new B cell differentiation antigen (BDA) on normal and leukemic human B lymphocytes that is distinct from known DR (Ia-like) antigens.
    Balch CM, Dougherty PA, Vogler LB, Ades EW, Ferrone S.
    J Immunol; 1978 Dec; 121(6):2322-8. PubMed ID: 102693
    [Abstract] [Full Text] [Related]

  • 40. Membrane antigen on Epstein--Barr virus-infected human B cells recognized by a monoclonal antibody.
    Slovin SF, Frisman DM, Tsoukas CD, Royston I, Baird SM, Wormsley SB, Carson DA, Vaughan JH.
    Proc Natl Acad Sci U S A; 1982 Apr; 79(8):2649-53. PubMed ID: 6283539
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.